Revenue (Tables)

12 Months Ended

Dec. 31, 2021

Revenue from Contract with Customer [Abstract]

Schedule of Disaggregation of Revenue

The following table presents the approximate percentage of our net sales by market group:

	2021		2020		2019
Biologics	41	%	31	%	25	%
Generics	17	%	20	%	20	%
Pharma	24	%	26	%	31	%
Contract-Manufactured Products	18	%	23	%	24	%
	100	%	100	%	100	%

The following table presents the approximate percentage of our net sales by product category:

	2021		2020		2019
High-Value Product Components	54	%	46	%	42	%
High-Value Product Delivery Devices	5	%	5	%	5	%
Standard Packaging	23	%	26	%	29	%
Contract-Manufactured Products	18	%	23	%	24	%
	100	%	100	%	100	%

The following table presents the approximate percentage of our net sales by geographic location:

	2021		2020		2019
Americas	45	%	48	%	48	%
Europe, Middle East, Africa	45	%	43	%	44	%
Asia Pacific	10	%	9	%	8	%
	100	%	100	%	100	%

Schedule of Change in Contract with Customer, Asset and Liability

The following table summarizes our contract assets and liabilities, excluding amounts included in accounts receivable, net:

	($ in millions)
Contract assets, December 31, 2020	$	10.9
Contract assets, December 31, 2021	14.6
Change in contract assets - increase (decrease)	$	3.7
Deferred income, December 31, 2020	$	(57.1)
Deferred income, December 31, 2021	(61.3)
Change in deferred income - (increase) decrease	$	(4.2)